AllNewsPhotosVideos
Serum Institute Of India

Serum Institute Of India

Serum institute of india, Latest News

Serum Institute of India is a manufacturer of immunobiological drugs including vaccines in India. It was founded by Cyrus Poonawalla in 1966.The company is the world's largest vaccine producer by number of doses produced. It is currently developing an intra-nasal swine flu vaccine.
Read More
DCGI grants regular market approval for Covishield, Covaxin with conditions - Hindi News | DCGI grants regular market approval for Covishield, Covaxin with conditions | Latest health News at Lokmattimes.com

Health :DCGI grants regular market approval for Covishield, Covaxin with conditions

New Delhi, Jan 27 The Drugs Controller General of India (DCGI) on Thursday granted regular market approval for ... ...

Thank govt for acknowledging my mentor, my hero: Adar Poonawalla on his father being conferred with Padma Bhushan - Hindi News | Thank govt for acknowledging my mentor, my hero: Adar Poonawalla on his father being conferred with Padma Bhushan | Latest national News at Lokmattimes.com

National :Thank govt for acknowledging my mentor, my hero: Adar Poonawalla on his father being conferred with Padma Bhushan

Chief Executive Officer of the Serum Institute of India (SII) Adar Poonawalla on Tuesday congratulated the deserving individuals who will receive the Padma awards this year. ...

SII Chairman and MD Cyrus Poonawalla to be conferred with Padma Bhushan - Hindi News | SII Chairman and MD Cyrus Poonawalla to be conferred with Padma Bhushan | Latest national News at Lokmattimes.com

National :SII Chairman and MD Cyrus Poonawalla to be conferred with Padma Bhushan

Serum Institute of India (SII) Chairman and Managing Director Cyrus Poonawalla will be conferred with Padma Bhushan, announced the Centre on Tuesday, on the eve of the 73rd Republic Day. ...

Covishield, Covaxin cleared for regular market approval - Hindi News | Covishield, Covaxin cleared for regular market approval | Latest health News at Lokmattimes.com

Health :Covishield, Covaxin cleared for regular market approval

New Delhi, Jan 19 India's two main vaccines Bharat Biotechs Covaxin and Serum Institute of India's Covishield ... ...

Timeline of India's COVID vaccination drive as it completes one-year today - Hindi News | Timeline of India's COVID vaccination drive as it completes one-year today | Latest national News at Lokmattimes.com

National :Timeline of India's COVID vaccination drive as it completes one-year today

Last year on January 16, India commenced the world's largest vaccination drive to vaccinate its massive population of around 1.38 billion against the COVID-19 infection. ...

SEC asks for more data to grant full market approval to Covaxin and Covishield - Hindi News | SEC asks for more data to grant full market approval to Covaxin and Covishield | Latest national News at Lokmattimes.com

National :SEC asks for more data to grant full market approval to Covaxin and Covishield

The Drugs Controller General of India's (DCGI) Subject Expert Committee (SEC) will continue thorough review of data submitted by the Serum Institute of India (SII) and Bharat Biotech for granting full market approval to Covaxin and Covishield, source ...

Novavax, Serum Institute file for emergency use authorisation of Novavax' COVID-19 vaccine in South Africa - Hindi News | Novavax, Serum Institute file for emergency use authorisation of Novavax' COVID-19 vaccine in South Africa | Latest international News at Lokmattimes.com

International :Novavax, Serum Institute file for emergency use authorisation of Novavax' COVID-19 vaccine in South Africa

Novavax, a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, and Serum Institute of India (SII), on Monday, announced a regulatory submission to the South African Health Produc ...

Covid antiviral drug Molnupiravir launched in India - Hindi News | Covid antiviral drug Molnupiravir launched in India | Latest health News at Lokmattimes.com

Health :Covid antiviral drug Molnupiravir launched in India

New Delhi, Jan 4 Covid antiviral drug Molnupiravir was on Monday launched in India at Rs 1,399 for ... ...